Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03959683 · ClinicalTrials.gov registry record · NA
ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03959683 is a NA study that has completed, run by Indiana University. The registered enrollment target is 100 participants.
The verdict
NCT03959683, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to measure how well two different devices work to break up and remove kidney stones. We are comparing a newer device to an older one to see which one is faster at breaking up kidney stones. We hypothesize that the Trilogy will increase the stone clearance rate by 25% compared to the Shockpulse-SE
Interventions
- DEVICE Trilogy Lithotrite
- DEVICE The ShockPulse-SE Lithotripsy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2020-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03959683
The ClinicalTrials.gov registry entry for NCT03959683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Trilogy Lithotrite is the first listed.
NCT03959683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03959683 about?
NCT03959683 is a clinical study titled "ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi". The purpose of this study is to measure how well two different devices work to break up and remove kidney stones. We are comparing a newer device to an older one to see which one is faster at breaking up kidney stones. We hypothesize that the Trilogy will increase the stone clearance rate by 25% com...
What is the current status of trial NCT03959683?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-02-19. Estimated completion is 2020-11-18.
What interventions are being tested in trial NCT03959683?
The interventions under investigation include: Trilogy Lithotrite (DEVICE), The ShockPulse-SE Lithotripsy System (DEVICE).
Who is sponsoring clinical trial NCT03959683?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.